The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Luminex Multiplex Assays-Global Market Insights and Sales Trends 2024
Synopsis
Luminex multiplex assays are driven by xMAP technology, designed to simultaneously detect and quantitate multiple secreted proteins (e.g., cytokines, chemokines, and growth factors) or expressed genes. This high-throughput technology produces results comparable to conventional assays such as ELISA and qPCR with greater efficiency and throughput.
The global Luminex Multiplex Assays market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Luminex Multiplex Assays in various end use industries. The expanding demands from the Pharmaceutical & Biotechnology Companies, Hospitals & Research Institutes and Others,, are propelling Luminex Multiplex Assays market. Protein Multiplex Assays, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Nucleic Acid Multiplex Assays segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Luminex Multiplex Assays market, driven by demand from China, the second largest economy with some signs of stabilising, the Luminex Multiplex Assays market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Luminex Multiplex Assays, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Luminex Multiplex Assays market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Luminex Multiplex Assays market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Luminex Multiplex Assays sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Luminex Multiplex Assays covered in this report include Thermo Fisher Scientific, R&D Systems, Bio-Rad Laboratories, Protavio, Illumina, BD, Luminex Corporation, Agilent Technologies and Bio-Techne Corporation, etc.
The global Luminex Multiplex Assays market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Thermo Fisher Scientific
R&D Systems
Bio-Rad Laboratories
Protavio
Illumina
BD
Luminex Corporation
Agilent Technologies
Bio-Techne Corporation
Shimadzu Biotech
Merck
Siemens Healthineers
Global Luminex Multiplex Assays market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Luminex Multiplex Assays market, Segment by Type:
Protein Multiplex Assays
Nucleic Acid Multiplex Assays
Cell-Based Multiplex Assays
Global Luminex Multiplex Assays market, by Application
Pharmaceutical & Biotechnology Companies
Hospitals & Research Institutes
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Luminex Multiplex Assays companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Luminex multiplex assays are driven by xMAP technology, designed to simultaneously detect and quantitate multiple secreted proteins (e.g., cytokines, chemokines, and growth factors) or expressed genes. This high-throughput technology produces results comparable to conventional assays such as ELISA and qPCR with greater efficiency and throughput.
The global Luminex Multiplex Assays market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Luminex Multiplex Assays in various end use industries. The expanding demands from the Pharmaceutical & Biotechnology Companies, Hospitals & Research Institutes and Others,, are propelling Luminex Multiplex Assays market. Protein Multiplex Assays, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Nucleic Acid Multiplex Assays segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Luminex Multiplex Assays market, driven by demand from China, the second largest economy with some signs of stabilising, the Luminex Multiplex Assays market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Luminex Multiplex Assays, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Luminex Multiplex Assays market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Luminex Multiplex Assays market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Luminex Multiplex Assays sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Luminex Multiplex Assays covered in this report include Thermo Fisher Scientific, R&D Systems, Bio-Rad Laboratories, Protavio, Illumina, BD, Luminex Corporation, Agilent Technologies and Bio-Techne Corporation, etc.
The global Luminex Multiplex Assays market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Thermo Fisher Scientific
R&D Systems
Bio-Rad Laboratories
Protavio
Illumina
BD
Luminex Corporation
Agilent Technologies
Bio-Techne Corporation
Shimadzu Biotech
Merck
Siemens Healthineers
Global Luminex Multiplex Assays market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Luminex Multiplex Assays market, Segment by Type:
Protein Multiplex Assays
Nucleic Acid Multiplex Assays
Cell-Based Multiplex Assays
Global Luminex Multiplex Assays market, by Application
Pharmaceutical & Biotechnology Companies
Hospitals & Research Institutes
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Luminex Multiplex Assays companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Luminex Multiplex Assays
1.1 Luminex Multiplex Assays Market Overview
1.1.1 Luminex Multiplex Assays Product Scope
1.1.2 Luminex Multiplex Assays Market Status and Outlook
1.2 Global Luminex Multiplex Assays Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Luminex Multiplex Assays Market Size by Region (2018-2029)
1.4 Global Luminex Multiplex Assays Historic Market Size by Region (2018-2023)
1.5 Global Luminex Multiplex Assays Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Luminex Multiplex Assays Market Size (2018-2029)
1.6.1 North America Luminex Multiplex Assays Market Size (2018-2029)
1.6.2 Europe Luminex Multiplex Assays Market Size (2018-2029)
1.6.3 Asia-Pacific Luminex Multiplex Assays Market Size (2018-2029)
1.6.4 Latin America Luminex Multiplex Assays Market Size (2018-2029)
1.6.5 Middle East & Africa Luminex Multiplex Assays Market Size (2018-2029)
2 Luminex Multiplex Assays Market by Type
2.1 Introduction
2.1.1 Protein Multiplex Assays
2.1.2 Nucleic Acid Multiplex Assays
2.1.3 Cell-Based Multiplex Assays
2.2 Global Luminex Multiplex Assays Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Luminex Multiplex Assays Historic Market Size by Type (2018-2023)
2.2.2 Global Luminex Multiplex Assays Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Luminex Multiplex Assays Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Luminex Multiplex Assays Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Luminex Multiplex Assays Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Luminex Multiplex Assays Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Luminex Multiplex Assays Revenue Breakdown by Type (2018-2029)
3 Luminex Multiplex Assays Market Overview by Application
3.1 Introduction
3.1.1 Pharmaceutical & Biotechnology Companies
3.1.2 Hospitals & Research Institutes
3.1.3 Others
3.2 Global Luminex Multiplex Assays Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Luminex Multiplex Assays Historic Market Size by Application (2018-2023)
3.2.2 Global Luminex Multiplex Assays Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Luminex Multiplex Assays Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Luminex Multiplex Assays Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Luminex Multiplex Assays Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Luminex Multiplex Assays Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Luminex Multiplex Assays Revenue Breakdown by Application (2018-2029)
4 Luminex Multiplex Assays Competition Analysis by Players
4.1 Global Luminex Multiplex Assays Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Luminex Multiplex Assays as of 2022)
4.3 Date of Key Players Enter into Luminex Multiplex Assays Market
4.4 Global Top Players Luminex Multiplex Assays Headquarters and Area Served
4.5 Key Players Luminex Multiplex Assays Product Solution and Service
4.6 Competitive Status
4.6.1 Luminex Multiplex Assays Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Thermo Fisher Scientific
5.1.1 Thermo Fisher Scientific Profile
5.1.2 Thermo Fisher Scientific Main Business
5.1.3 Thermo Fisher Scientific Luminex Multiplex Assays Products, Services and Solutions
5.1.4 Thermo Fisher Scientific Luminex Multiplex Assays Revenue (US$ Million) & (2018-2023)
5.1.5 Thermo Fisher Scientific Recent Developments
5.2 R&D Systems
5.2.1 R&D Systems Profile
5.2.2 R&D Systems Main Business
5.2.3 R&D Systems Luminex Multiplex Assays Products, Services and Solutions
5.2.4 R&D Systems Luminex Multiplex Assays Revenue (US$ Million) & (2018-2023)
5.2.5 R&D Systems Recent Developments
5.3 Bio-Rad Laboratories
5.3.1 Bio-Rad Laboratories Profile
5.3.2 Bio-Rad Laboratories Main Business
5.3.3 Bio-Rad Laboratories Luminex Multiplex Assays Products, Services and Solutions
5.3.4 Bio-Rad Laboratories Luminex Multiplex Assays Revenue (US$ Million) & (2018-2023)
5.3.5 Protavio Recent Developments
5.4 Protavio
5.4.1 Protavio Profile
5.4.2 Protavio Main Business
5.4.3 Protavio Luminex Multiplex Assays Products, Services and Solutions
5.4.4 Protavio Luminex Multiplex Assays Revenue (US$ Million) & (2018-2023)
5.4.5 Protavio Recent Developments
5.5 Illumina
5.5.1 Illumina Profile
5.5.2 Illumina Main Business
5.5.3 Illumina Luminex Multiplex Assays Products, Services and Solutions
5.5.4 Illumina Luminex Multiplex Assays Revenue (US$ Million) & (2018-2023)
5.5.5 Illumina Recent Developments
5.6 BD
5.6.1 BD Profile
5.6.2 BD Main Business
5.6.3 BD Luminex Multiplex Assays Products, Services and Solutions
5.6.4 BD Luminex Multiplex Assays Revenue (US$ Million) & (2018-2023)
5.6.5 BD Recent Developments
5.7 Luminex Corporation
5.7.1 Luminex Corporation Profile
5.7.2 Luminex Corporation Main Business
5.7.3 Luminex Corporation Luminex Multiplex Assays Products, Services and Solutions
5.7.4 Luminex Corporation Luminex Multiplex Assays Revenue (US$ Million) & (2018-2023)
5.7.5 Luminex Corporation Recent Developments
5.8 Agilent Technologies
5.8.1 Agilent Technologies Profile
5.8.2 Agilent Technologies Main Business
5.8.3 Agilent Technologies Luminex Multiplex Assays Products, Services and Solutions
5.8.4 Agilent Technologies Luminex Multiplex Assays Revenue (US$ Million) & (2018-2023)
5.8.5 Agilent Technologies Recent Developments
5.9 Bio-Techne Corporation
5.9.1 Bio-Techne Corporation Profile
5.9.2 Bio-Techne Corporation Main Business
5.9.3 Bio-Techne Corporation Luminex Multiplex Assays Products, Services and Solutions
5.9.4 Bio-Techne Corporation Luminex Multiplex Assays Revenue (US$ Million) & (2018-2023)
5.9.5 Bio-Techne Corporation Recent Developments
5.10 Shimadzu Biotech
5.10.1 Shimadzu Biotech Profile
5.10.2 Shimadzu Biotech Main Business
5.10.3 Shimadzu Biotech Luminex Multiplex Assays Products, Services and Solutions
5.10.4 Shimadzu Biotech Luminex Multiplex Assays Revenue (US$ Million) & (2018-2023)
5.10.5 Shimadzu Biotech Recent Developments
5.11 Merck
5.11.1 Merck Profile
5.11.2 Merck Main Business
5.11.3 Merck Luminex Multiplex Assays Products, Services and Solutions
5.11.4 Merck Luminex Multiplex Assays Revenue (US$ Million) & (2018-2023)
5.11.5 Merck Recent Developments
5.12 Siemens Healthineers
5.12.1 Siemens Healthineers Profile
5.12.2 Siemens Healthineers Main Business
5.12.3 Siemens Healthineers Luminex Multiplex Assays Products, Services and Solutions
5.12.4 Siemens Healthineers Luminex Multiplex Assays Revenue (US$ Million) & (2018-2023)
5.12.5 Siemens Healthineers Recent Developments
6 North America
6.1 North America Luminex Multiplex Assays Market Size by Country (2018-2029)
6.2 United States
6.3 Canada
7 Europe
7.1 Europe Luminex Multiplex Assays Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Luminex Multiplex Assays Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Luminex Multiplex Assays Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Luminex Multiplex Assays Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Luminex Multiplex Assays Market Dynamics
11.1 Luminex Multiplex Assays Industry Trends
11.2 Luminex Multiplex Assays Market Drivers
11.3 Luminex Multiplex Assays Market Challenges
11.4 Luminex Multiplex Assays Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
